Evercore analysts have upgraded their rating on Oracle (NYSE:ORCL) from 'In Line' to 'Outperform' and increased their price target from $131 to $135, suggesting a 23% upside. This comes after Oracle's stock dropped 13% following Q1 results that didn't meet expectations. Despite challenges with the recently acquired Cerner healthcare software business, Evercore believes the post-results pullback offers a good entry point for investors. They expect Oracle's core cloud offering to account for half of total revenue by fiscal 2026, boosting revenue to $62.9 billion.